FilingSEC EDGAR8-K
NRx Pharmaceuticals Subsidiary Awarded $11.2 Million DARPA Contract for Clinical Trial
· SEC accepted
StageClinical Trial Initiation
Filing content
NRx Pharmaceuticals' subsidiary, NRx Defense Systems, announced it has been awarded an $11.2 million contract by DARPA to conduct a clinical trial for depression treatment.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…